ipilimumab,nivolumab,cabozantinib
exelixis,bms
['vance', 'kidney cancer', 'cosmic-313', 'pivotal', 'exelixis']
exelixis announces detailed results from phase 3 cosmic-313 pivotal trial in patients with previously untreated advanced kidney cancer at esmo 2022 #clinicalresearch #clinicaltrials #cosmic-313 #exelixis